Brady Cook, MD
Internal Medicine · Idaho Falls, IDNPI 1467502930
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 361 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 41 manufacturers reported payments, led by Amgen at 35.9% of the total. Among internal medicine clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 361 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$601
- Novo Nordisk$344
- GSK$316
- Boehringer Ingelheim$205
- Mylan Specialty L.p.$186
- plus $2K from 35 others
What the payments were for
- Food & beverage$5,502100%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 152 | $1,982 |
| AbbVie(2 entities) | 29 | $601 |
| Novo Nordisk | 28 | $344 |
| GSK | 22 | $316 |
| Boehringer Ingelheim | 12 | $205 |
| Mylan Specialty L.p. | 10 | $186 |
| Lilly USA, LLC | 13 | $168 |
| Astellas Pharma US Inc | 6 | $144 |
| Medtronic(2 entities) | 9 | $138 |
| Pfizer | 9 | $124 |
| Johnson & Johnson | 8 | $124 |
| Novartis | 6 | $116 |
| Penumbra, Inc. | 1 | $107 |
| AstraZeneca | 6 | $83 |
| Dexcom, Inc. | 4 | $71 |
| GE HealthCare | 2 | $59 |
| Abbott | 3 | $59 |
| Insulet Corporation | 3 | $54 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Edwards Lifesciences | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $38 |
| Bayer | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Tandem Diabetes Care, Inc. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Merck | 2 | $29 |
| Corcept Therapeutics | 2 | $28 |
| Kerecis Limited | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$107
How this compares
$5,528 in reported general payments places this provider in the 95th percentile of 289 internal medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 175 | $193,663 |
| MounjaroTirzepatide | 131 | $154,683 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 13 | $124,714 |
| OzempicSemaglutide | 39 | $54,686 |
| XareltoRivaroxaban | 40 | $37,440 |
| FarxigaDapagliflozin Propanediol | 25 | $37,363 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $22,407 |
| RybelsusSemaglutide | 16 | $21,996 |
| Bosentan | 24 | $19,731 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $12,876 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $9,711 |
| Celecoxib | 94 | $7,647 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $6,710 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $6,533 |
| Aripiprazole | 23 | $6,139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $124 | $193,663175 claims |
| Lilly USA, LLCMounjaro, Humalog | $168 | $157,599153 claims |
| Novo NordiskOzempic, Rybelsus | $344 | $76,68155 claims |
| Johnson & JohnsonXarelto | $124 | $37,44040 claims |
| AstraZenecaFarxiga | $83 | $37,36325 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $316 | $22,58731 claims |
| Actelion Pharmaceuticals US, Inc.Bosentan | $33 | $19,73124 claims |
| AbbVieSynthroid | $601 | $1,46628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 289 internal medicine providers in Idaho.
Other internal medicine in Idaho Falls
- Susan WachterIdaho Falls$22K
- Ahmed MahmoodIdaho Falls$21K
- Kevin PrierIdaho Falls$6K
- Scott TaylorIdaho Falls$5K
- Johnathan LiljenquistIdaho Falls$525
- Leland KrantzIdaho Falls$447
- Alan AvondetIdaho Falls$411
- Margaret BakerIdaho Falls$403
- Allen SwansonIdaho Falls$303
- Sherwin D'souzaPocatello$543K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.